American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Journal of Oncology Practice

Volumn 6, Issue 4, 2010, Pages 195-197

  Hammond, M Elizabeth H ^a   Hayes, Daniel F ^a   Wolff, Antonio C ^a   Mangu, Pamela B ^a   Temin, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST BIOPSY; BREAST CANCER; CANCER HORMONE THERAPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MANDATORY REPORTING; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; SHORT SURVEY; TUMOR BIOPSY;

EID: 78149287242     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.777003     Document Type: Short Survey

References (3)

1. Hammond MEH, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795, 2010
2. Hammond MEH, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:E1-E16, 2010
3. Wolff AC, Hammond MEH, Schwartz JN, et al: American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145, 2007